1. Home
  2. ALGS vs BHAT Comparison

ALGS vs BHAT Comparison

Compare ALGS & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGS
  • BHAT
  • Stock Information
  • Founded
  • ALGS 2018
  • BHAT 2010
  • Country
  • ALGS United States
  • BHAT China
  • Employees
  • ALGS N/A
  • BHAT N/A
  • Industry
  • ALGS Biotechnology: Pharmaceutical Preparations
  • BHAT Recreational Games/Products/Toys
  • Sector
  • ALGS Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • ALGS Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • ALGS 56.7M
  • BHAT 59.1M
  • IPO Year
  • ALGS 2020
  • BHAT 2019
  • Fundamental
  • Price
  • ALGS $9.74
  • BHAT $1.31
  • Analyst Decision
  • ALGS Strong Buy
  • BHAT
  • Analyst Count
  • ALGS 2
  • BHAT 0
  • Target Price
  • ALGS $60.00
  • BHAT N/A
  • AVG Volume (30 Days)
  • ALGS 90.2K
  • BHAT 50.2K
  • Earning Date
  • ALGS 11-06-2025
  • BHAT 12-22-2025
  • Dividend Yield
  • ALGS N/A
  • BHAT N/A
  • EPS Growth
  • ALGS N/A
  • BHAT N/A
  • EPS
  • ALGS N/A
  • BHAT N/A
  • Revenue
  • ALGS $2,646,000.00
  • BHAT $18,724,190.00
  • Revenue This Year
  • ALGS N/A
  • BHAT N/A
  • Revenue Next Year
  • ALGS N/A
  • BHAT N/A
  • P/E Ratio
  • ALGS N/A
  • BHAT N/A
  • Revenue Growth
  • ALGS N/A
  • BHAT N/A
  • 52 Week Low
  • ALGS $3.76
  • BHAT $1.07
  • 52 Week High
  • ALGS $46.80
  • BHAT $24.50
  • Technical
  • Relative Strength Index (RSI)
  • ALGS 62.50
  • BHAT 41.63
  • Support Level
  • ALGS $5.81
  • BHAT $1.07
  • Resistance Level
  • ALGS $7.00
  • BHAT $1.57
  • Average True Range (ATR)
  • ALGS 0.79
  • BHAT 0.08
  • MACD
  • ALGS 0.38
  • BHAT -0.01
  • Stochastic Oscillator
  • ALGS 88.61
  • BHAT 51.98

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.

Share on Social Networks: